Explore how AI in high-throughput screening improves drug discovery through advanced data analysis, hit identification and ...
Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among the most expensive to develop, as animal model results have not proven to ...
Master ultra-high-throughput screening principles. Learn how advanced automation and miniaturization accelerate drug ...
High Throughput Screening Market to Reach USD 17,880 Million by 2031, Driven by Drug Discovery Advancements | Valuates Reports ...
Surface plasmon resonance (SPR) offers researchers a powerful way to observe molecular interactions directly, measuring binding events with exceptional sensitivity and without fluorescent or chemical ...
In the race of innovative drug R&D, whether for antibodies, peptides, or novel binding proteins, the efficiency of early-stage molecule discovery is always the key factor determining project success ...
DeepCyte, a techbio company building AI toxicology tools for drug development, launched today with $1.5 million in seed funding. The company is introducing two solutions to help biopharma teams detect ...
A novel optogenetic screening platform enables control over previously intractable biological systems. Using the screening platform, scientists have been able to selectively activate the integrated ...
High-throughput mass spectrometry (HT-MS) has emerged as an indispensable tool in drug discovery, offering rapid, sensitive and label‐free detection of biochemical transformations. By coupling ...
Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results